First argentine consensus for standardization of antinuclear antibodies by indirect immunofluorescence-HEp-2;Primer consenso argentino para la estandarización de la determinación de anticuerpos anti-nucleares por inmunofluorescencia indirecta-HEp-2

Acta Bioquimica Clinica Latinoamericana

Volumn 46, Issue 1, 2012, Pages 3-13

  Carballo, Orlando Gabriel ^a,e,f   Ingénito, Fernanda Beatriz ^a   Ginaca, Alejandra Andrea ^b   Carabajal, Patricia ^b   Costa, Marta Alicia ^c   Balbaryski, Jeannette ^d  

^a HOSPITAL DURAND   (Argentina)

^b HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^c HOSPITAL ALEMÁN   (Argentina)

^d HOSPITAL GENERAL DE NIÑOS PEDRO DE ELIZALDE   (Argentina)

^e HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^f NONE

Author keywords

Antinuclear antibodies; HEp 2; Immunofluorescence

Indexed keywords

EID: 84862005246     PISSN: 03252957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune disease and probes for cell biology. Acv Immunol 1989; 44: 93-151. (Pubitemid 19090837)
2. Hahn BH. Antibodies to DNA. N Engl J Med 1998; 338:1359-68. (Pubitemid 28216666)
3. von Mühlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic disease. Semin Arthitis Rheum 1995; 24: 323-58.
4. Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ. et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997; 40: 1601-11. (Pubitemid 27426153)
5. Mill JA. Systemic lupus erythematosus. N Eng J Med 1994; 330: 871-9.
6. Hargraves M, Richmond H, Morton R. Presentation of two bone marrow components, the tart cell and the LE cell. Mayo Clin Proc 1948; 27: 25-28.
7. Holborow EJ, Weir DM, Johnson GD. A serum factor in lupus erythematosus with affinity for tissue nuclei. Br Med J 1957; 2: 732-57.
8. Friou CJ. Clinical application of lupus serum nucleoprotein reaction using fluorescent antibody technique. J Clin Invest 1957; 36: 890-7.
9. Holman HR, Kunkel HG. Affinity between the LE factor and cell nucleic acid nucleoprotein. Science 1957; 126: 162-3.
10. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF. et al. The 1982 revised criteria for the classification of systemis lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7. (Pubitemid 13221242)
11. Damoiseaux JGMC, Cohen Tervaert JW. From ANA to ENA: How to proceed. Autoimmun Rev 2006; 5(1): 10-17.
12. Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and teas for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med 2000; 124: 71-81. (Pubitemid 30053777)
13. Carballo OG, Sarchi MI, Di Lonardo AM. Taller de Autoanticuerpos Antinucleares (ANA): una experiencia Latinoamericana. M Rev Mex Reumatol 1999; 14: 43-50.
14. Dellavance A, Junior AG, Cintra AFU, Ximenes AC, Nuccitelli B, von Mühlen CA, et al. I Consenso Nacional Para Padronização dos Laudos de FAN HEp-2 .Rio de Janeiro, J Bras Paol Med Lab 2002; 38: 3.
15. Dellavance A, Junior AG, Cintra AFU, Ximenes AC, Nuccitelli B, Taliberti BH, et al. II Consenso Brasileiro de Fator Antinuclear em Células HEp-2 Definições para a padronização da pesquisa de auto-anticorpos contra constituintes do núcleo (FAN HEp-2), nucléolo, citoplasma e aparelho mitótico e suas associações clínicas. Rev Bras Reumatol 2003; 43 (3): 129-140.
16. Dellavance A, Júnior AG, Nuccitelli B, Taliberti BH, von Mühlen CA, Araújo Bichara CD. Third Brazilian Consensus for autoantibodies in HEp-2 cells (ANA). Recommendations for standardization of autoantibodies screening Trial in HEp-2 cell, quality control and clinical associations. Rev Bras Reumatol 2009; 49 (2): 89-109.
17. NCCLS. Quality Assurance for the Indirect Immunofluorescence Test for Autoantibodies to Nuclear Antigen (IF-ANA); Approved Guideline. NCCLS document I/LA2-A (ISBN 1- 56238-311-6). NCCLS, 940. West Valley Road, Suite 1400, Wayne, Pennsylvania 19087, 1996.
18. Rose NR, Bigazzi PE. Methods in Immunodiagnosis. (2° ed) New York, Chiester, Brisbane, Toronto: John Wiley and Sons; 1980.
19. Feltkamp TEW, Klein F, Janssens MBJA. Standardisation of the quantitative determination of antinuclear antibodies (ANAs) with a homogeneous pattern. Ann Rheumatic Dis 1988; 47: 906-9. (Pubitemid 18263860)
20. Ghosh P, Dwivedi S, Naik S, Agarwal V, Verma A, Agarwal A. Antinuclear antibodies by indirect immunofluorescence: Optimun screening dilution for diagnosis of systemic lulus erythematosus. Indian J Med Res 2007; 126:34. pp. 34-8. (Pubitemid 350020545)
21. McGhee JL, Kickingbird LM, Jarvis JN. Clinical utility of nuclear antibodies test in children. Clinical utility of antinuclear antibodies test in Children. BMC Pediatrics 2004; 4:13.
22. Carballo OG, von Muhlen CA, Nakamura R, García de la Torre I, Carvahlho Francescantonio PL. Atlas, Anticuerpos anti- nucleocitoplasmáticos (HEp-2). Buenos Aires: JC Ciccolella; 2006.
23. Gladman DD, Chalmers A, Urowitz, MB. Systemic lupus erithematosus with negative cells and antinuclear factor. J Rheumatol 1978; 5: 142-7. (Pubitemid 8367090)
24. Maddison PJ, Provost TT, Reichlin M. Serological findings in patiens with ANA-negative systemic lupus erythematosus. Medicine (Baltimore) 1981; 60: 87-94.
25. Solomon DH, Kavanaugh AJ, Schur PH and The American Collage of Rheumatology ad hoc Committee on Immunologic Testing Guidelines. Arthritis Rheum 2002; 47 (4): 434-44.